NCT00004256View on ClinicalTrials.gov

Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 1997

Study Completion Date

July 31, 2006

Conditions
Head and Neck CancerOral ComplicationsRadiation Toxicity
Interventions
BIOLOGICAL

sargramostim

PROCEDURE

quality-of-life assessment

RADIATION

radiation therapy

Trial Locations (1)

SW3 6JJ

Royal Marsden NHS Trust, London

All Listed Sponsors
lead

Royal Marsden NHS Foundation Trust

OTHER

NCT00004256 - Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer | Biotech Hunter | Biotech Hunter